Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Higher risk of contamination Bacteria or mold can develop in expired liquid formulations, potentially leading to infections
AOD-9604 Dosage Protocols AOD-9604 is typically administered via subcutaneous injection, though compounded versions in capsules or troches also exist
Products are for qualified researchers in academic, pharmaceutical or biotechnology settings with appropriate training and facilities
A higher growth hormone receptor expression may potentially enhance its proliferative stimulus and contribute to healing effects on these tissues
development as an obesity drug was not continued
Clinical trials in humans are needed to confirm efficacy and long-term safety
US$ 23.34
US$ 26.46
US$ 25.75
US$ 29.09
US$ 29.33
